Nearly 415 million adults in the world have diabetes, as of 2015, and researchers say this number will continue to rise, reports Abigail Klein Leichman at Israel21c. Thankfully, Israeli researchers continue to develop innovative ways to either avoid or manage the disease. Check out the first innovation on their list:
Oramed Pharmaceuticals hopes to revolutionize the treatment of type 1 and type 2 diabetes through its proprietary oral insulin capsule developed through research at Jerusalem’s Hadassah Medical Center. Currently, insulin must be injected.
The company has completed multiple Phase II clinical trials under an Investigational New Drug application with the US Food and Drug Administration. Oramed CEO Nadav Kidron participated in the 2017 Disruptive Growth Company Showcase NYC Conference in September in New York City.